A Randomized Controlled Study of Conservative Treatment of Granulomatous Lobular Mastitis Combined With Psychiatric Disorders
Launched by WUHAN UNIVERSITY · May 24, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18 years or older with granulomatous lobular mastitis
- • Patients with Psychiatric Disorders;
- • Patients volunteered to participate in the study after informed consent.
- Exclusion Criteria:
- • Patients were diagnosed with mastitis with other definite etiology confirmed by pathology
- • Patients in acute exacerbation of mental illness
About Wuhan University
Wuhan University, a prestigious research institution located in Wuhan, China, is renowned for its commitment to advancing medical science and improving public health through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive academic resources and expertise to conduct rigorous clinical studies aimed at exploring novel therapies and interventions. The institution is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Patients applied
Trial Officials
Gaosong Wu
Study Director
Wuhan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials